Sign in

CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473506994
Phone
5105052680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Planned sale Chief Legal Officer sold 6,244 shares at $27.50 ($171,710)
  8. 4 Planned sale Chief Executive Officer sold 92,001 shares at $27.13 ($2,495,822)
  9. 8-K Event Other events
  10. 144 Insider Sale of Securities
  11. 424B5 Offering Prospectus
  12. 144 Insider Sale of Securities
  13. 4 Planned sale Chief Medical Officer sold 24,552 shares at $30.05 ($737,788)
  14. 3/A Insider 3/A
  15. FWP Offering Free Writing Prospectus
  16. 424B5 Offering Prospectus
  17. S-3ASR Offering Registration Statement
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 4 Open-market sale Chief Executive Officer sold 5,696 shares at $18.41 ($104,851)
  20. 144 Insider Sale of Securities

Page 11 of 23 · 442 filings